Clinical characteristics of primary AIHA patients
. | N* . |
---|---|
Patients, N | 308 |
Male/female | 111 (36)/197 (64) |
Median age at onset, y (range) | 58 (0-95) |
<18 y | 10 (3) |
18-45 y | 73 (24) |
45-65 y | 104 (34) |
>65 y | 121 (39) |
AIHA serological type** | |
Warm, DAT positive for IgG | 131 (43) |
Warm, DAT positive for IgG+C | 52 (17) |
CAD | 84 (27) |
Mixed | 24 (8) |
Atypical | 16 (5) |
Median follow-up, mo (range) | 33 (6-372) |
Alive/dead at time of study† | 221 (72)/63 (21) |
Died of AIHA | 11/63 (17) |
. | N* . |
---|---|
Patients, N | 308 |
Male/female | 111 (36)/197 (64) |
Median age at onset, y (range) | 58 (0-95) |
<18 y | 10 (3) |
18-45 y | 73 (24) |
45-65 y | 104 (34) |
>65 y | 121 (39) |
AIHA serological type** | |
Warm, DAT positive for IgG | 131 (43) |
Warm, DAT positive for IgG+C | 52 (17) |
CAD | 84 (27) |
Mixed | 24 (8) |
Atypical | 16 (5) |
Median follow-up, mo (range) | 33 (6-372) |
Alive/dead at time of study† | 221 (72)/63 (21) |
Died of AIHA | 11/63 (17) |